Error loading player: No playable sources found
3285
Intestinal Inflammation, Fibrosis, and Regeneration
Date
May 19, 2024
Tracks
Related Products
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
"Clinical Correlation Suggested": How to Handle Discrepancies Between Clinical and Pathologic Findings in Inflammatory GI Biopsies
SOCIETY: AGA This symposium focuses on frustrating scenarios where histopathologic examination of inflammatory gastrointestinal tract biopsies shows findings that do not match a patient's clinical scenario or provide a challenging differential diagnosis…
AGA Beyond Gut Bacteria: Transkingdom Interactions Underlying GI Diseases
Through the history of gut microbiome research, basic, translational, and clinical studies revealed many critical roles played by gut-resident bacteria in affecting human health and disease…
2024 AGA Guideline Highlights
SOCIETY: AGA AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology…